GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ascletis Pharma Inc (HKSE:01672) » Definitions » FCF Yield %

Ascletis Pharma (HKSE:01672) FCF Yield % : -12.97 (As of May. 18, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Ascletis Pharma FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Ascletis Pharma's Trailing 12-Month Free Cash Flow is HK$-178.64 Mil, and Market Cap is HK$1,367.22 Mil. Therefore, Ascletis Pharma's FCF Yield % for today is -12.97%.

The historical rank and industry rank for Ascletis Pharma's FCF Yield % or its related term are showing as below:

HKSE:01672' s FCF Yield % Range Over the Past 10 Years
Min: -15.26   Med: -4.69   Max: -2.28
Current: -12.97


During the past 8 years, the highest FCF Yield % of Ascletis Pharma was -2.28%. The lowest was -15.26%. And the median was -4.69%.

HKSE:01672's FCF Yield % is ranked better than
51.83% of 1557 companies
in the Biotechnology industry
Industry Median: -14.14 vs HKSE:01672: -12.97

Ascletis Pharma's FCF Margin % for the quarter that ended in Dec. 2023 was -924.69%.


Ascletis Pharma FCF Yield % Historical Data

The historical data trend for Ascletis Pharma's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ascletis Pharma FCF Yield % Chart

Ascletis Pharma Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Yield %
Get a 7-Day Free Trial -3.47 -4.63 -5.24 -4.70 -11.73

Ascletis Pharma Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.55 -6.37 -4.55 -7.53 -13.41

Competitive Comparison of Ascletis Pharma's FCF Yield %

For the Biotechnology subindustry, Ascletis Pharma's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ascletis Pharma's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ascletis Pharma's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Ascletis Pharma's FCF Yield % falls into.



Ascletis Pharma FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Ascletis Pharma's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-178.636 / 1522.3712
=-11.73%

Ascletis Pharma's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-102.049 * 2 / 1522.3712
=-13.41%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ascletis Pharma FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Ascletis Pharma FCF Yield % Related Terms

Thank you for viewing the detailed overview of Ascletis Pharma's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Ascletis Pharma (HKSE:01672) Business Description

Traded in Other Exchanges
Address
198 Qidi Road, 12th Floor, Building D, HIPARK, Xiaoshan District, Zhejiang Province, Hangzhou, CHN, 311200
Ascletis Pharma Inc is an investment holding company engaged in the research and development, production, marketing, and sale of pharmaceutical products. It has three marketed products, i.e. ritonavir tablets, GANOVO, and ASCLEVIR. Geographically, it operates in Mainland China and other countries.

Ascletis Pharma (HKSE:01672) Headlines

No Headlines